Free Newsletter
Register for our Free Newsletters
Zones
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Materials
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
 
 
 
 
 
 
 
 
News

Abiomed partners Opsens to integrate fibre optic sensors in catheters

Abiomed : 28 January, 2010  (Application Story)
Abiomed forms a strategic partnership with Opsens, a leading developer of fibre optic sensors which will see Opsens' breakthrough sensor technology being integrated into the Impella catheter to provide robust blood pressure measurements that can be used to enhance Impella's performance and ease-of-use.
Impella, the World's Smallest Heart Pump, has supported more than 1,600 patients in the USA and more than 3,000 patients worldwide. Over the past fiscal year 2010, product enhancements to the Impella have included a new introducer sheath and a quick set-up software and kit, which have allowed customers to reduce the Impella set-up time from 11 minutes to two minutes. Through this latest enhancement, Opsens' fiber optic sensors will be integrated into the Impella Catheter and will allow for further improvements in set-up time, as well as provide a high-quality pressure monitoring capability that can eventually be used to help automate the control and operation of the Impella pump. Unlike current fiber optic sensors used on other cardiac assist devices today such as certain Intra-Aortic Balloons (IABs), Opsens' fibre optic sensor is designed to provide longer-term accuracy and reliability. 'This partnership with Opsens further demonstrates Abiomed's commitment to continue enhancing and updating Impella technology and providing better results for customers,' said David Weber, Chief Operating Officer of Abiomed. 'By integrating Opsens' technology into our Impella platform, we can provide our customers with even more calculated control and insight during their high-risk and emergent procedures.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com